Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thealoz Total Eye Drops in Chronic Dry Eye Disease
NCT07245836Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Thealoz Total in dry eye disease (DED), sponsored by Medical University of Vienna. Started Jan 2025; status: terminated.
02
Drugs
Thealoz Total
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07245836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245836.